In obtained tumor tissues 6 days after the beginning of the therapy necrosis, apoptosis, hypoxia, proliferation, number of blood vessels, granzyme B-positive cells, and the presence of TNF-α and IL-12 were immunohistologically evaluated in relation to control, untreated tumors, and other pertinent controls. The gene discussed is GZMB; the disease is neoplasm.